Breast Cancer Screening in Women With Multiple Sclerosis: A Mixed‐Methods Study
European Journal of Neurology · 2025
DOI: 10.1111/ene.70183 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Chloe Pierret und 2 weiteren Autor:innen. Beteiligte Einrichtung: Rennes University, EHESP, CNRS, Inserm, ARENES UMR 6051, RSMS U 1309, Rennes, France. Hauptthemen laut MEDLINE: Multiple Sclerosis, Breast Neoplasms, Mammography, Early Detection of Cancer. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques, EDMUS Foundation, Institut des Neurosciences Cliniques de Rennes.
Abstract (Originalsprache)
Background
There is little information on breast cancer screening (BCS) practices in women with multiple sclerosis (WwMS).
Objective
To assess and compare BCS rates in WwMS and in the general population and identify barriers and facilitators.
Methods
In a 2012–2020 cohort study, we identified 47,166 WwMS without a history of cancer and matched them (up to 1:4) to 184,124 controls from the French national medico‐administrative database. Mammography rates were compared according to age, city‐level socio‐economic status, period, and DMT use. We used logistic and negative binomial models to identify factors associated with BCS adherence in WwMS. We also carried out semistructured interviews with 20 WwMS and analyzed them using the empirically inductive method.
Results
Compared with controls, fewer WwMS underwent BCS at least once (69.9% vs. 76.7%, p < 0.001) and had a lower biennial mammography rate (0.55 vs. 0.63; p < 0.001). Rate differences increased with age. Once stratified on DMT, age‐standardized rates only differed in the non‐treated group (0.51 vs. 0.64; p < 0.001). Factors associated with lower mammography rates in WwMS were city‐level socio‐economic status (mostdeprived vs. least deprived; IRR 0.88 95% CI [0.86–0.91]), long MS duration (16–25 years: 0.91 [0.89–0.94]; ref: ≤ 5) and hospitalization (MS‐related: 0.85 [0.82–0.88]; non‐MS‐related: 0.92 [0.89–0.94]). However, DMT use was associated with higher mammography rates (high efficacy: 1.17 [1.14–1.21]; moderate efficacy: 1.18 [1.16–1.20]). Barriers were physical disability and feeling of excessive medicalization. Facilitators were disability‐accessible care and perception of BCS as a routine procedure.
Conclusion
BCS among WwMS is suboptimal, especially among those not treated by DMT, and needs to be improved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rennes University, EHESP, CNRS, Inserm, ARENES UMR 6051, RSMS U 1309, Rennes, France.
ORCID-Profile: Chloe Pierret, Emmanuelle Leray
Förderung
- Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques
- EDMUS Foundation
- Institut des Neurosciences Cliniques de Rennes
- Matmut Paul Bennetot Foundation - INSPIRE Chair
Zitieren
APA
Pierret, C., Philippe, L., & Leray, E. (2025). Breast Cancer Screening in Women With Multiple Sclerosis: A Mixed‐Methods Study. European Journal of Neurology. https://doi.org/10.1111/ene.70183
Vancouver
Pierret C, Philippe L, Leray E. Breast Cancer Screening in Women With Multiple Sclerosis: A Mixed‐Methods Study. European Journal of Neurology. 2025. doi:10.1111/ene.70183
BibTeX
@article{Pierret2025,
author = {Pierret, Chloe and Philippe, Lou and Leray, Emmanuelle},
title = {Breast Cancer Screening in Women With Multiple Sclerosis: A Mixed‐Methods Study},
journal = {European Journal of Neurology},
year = {2025},
doi = {10.1111/ene.70183}
}
EUVIMED